PeptiDream Inc.
PPTDF
Get informed when a big investor buys or sells
+ FollowMarket Cap$138.13B
Close$
Share Statistics
| Market cap | $138.13 Billion |
|---|---|
| Enterprise Value | $130.86 Billion |
| Dividend Yield | $- (-) |
| Earnings per Share | $-29.8 |
| Beta | 0.53 |
| Outstanding Shares | 128,567,724 |
Return
| Return on Equity | -7.55% |
|---|---|
| Return on Assets | -5.07% |
| Return on Invested Capital | -7.58% |
Valuation & Multiples
| P/E Ratio | -38.24 |
|---|---|
| PEG | -0.26 |
| Price to Sales | 0.05 |
| Price to Book Ratio | 0.02 |
| Enterprise Value to Revenue | 6.79 |
| Enterprise Value to EBIT | -27.05 |
| Enterprise Value to Net Income | -36 |
| Total Debt to Enterprise | 0.12 |
| Debt to Equity | 0.34 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
August 12, 2026
EPS Estimate
$-0.02
Average shareholder expectationRevenue Estimate
$34.90 M
Average shareholder expectationNext Earnings Call
Expected Date
November 11, 2026
EPS Estimate
$-0.04
Average shareholder expectationRevenue Estimate
$32.12 M
Average shareholder expectationInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About PeptiDream Inc.
763 employees
CEO: Patrick Crawford Reid PeptiDream Inc. functions as a biopharmaceutical enterprise, concentrating on the identification and progression of therapeutic compounds such as constrained peptides, small molecules, and peptide-drug conjugates. The company's unique pr...